Aria PharmaceuticalsMore Progress, with More ConfidenceBy: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals4 min read·Dec 19, 2022----
Aria PharmaceuticalsWe Must Unblock the Sharing of DataBy: Aaron C. Daugherty, VP of Discovery, Aria Pharmaceuticals4 min read·Nov 9, 2022----
Aria PharmaceuticalsMoving the dialogue forward: The need for better AI integration in drug discoveryBy: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals5 min read·Mar 16, 2022----
Aria PharmaceuticalsA New Era of Hope for Idiopathic Pulmonary FibrosisBy: Anjali Pandey, Ph.D.4 min read·Sep 30, 2021----
Aria PharmaceuticalsWhat’s In A Name? Artistry and Sound Science!By: Andrew A. Radin4 min read·May 26, 2021----
Aria PharmaceuticalsR&D Is Changing And I’m On Boardby: Mark Eller, Ph.D. SVP of R&D, twoXAR3 min read·Mar 31, 2021----
Aria PharmaceuticalsThis Year’s JPM Healthcare Conference Should Give Our Industry ConfidenceAndrew A. Radin CEO, twoXAR Pharmaceuticals4 min read·Jan 21, 2021----
Aria PharmaceuticalsLooking forward to 2021 at twoXARAndrew A. Radin CEO, twoXAR Pharmaceuticals5 min read·Dec 16, 2020----
Aria PharmaceuticalsWhy twoXAR Pharmaceuticals isn’t working on COVID-19by: Andrew A. Radin CEO, twoXAR3 min read·Oct 28, 2020----